Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

Lehmann, S.
Ravn, A.
Carlsson, L.
Antunovic, P.
Deneberg, S.
Mollgard, L.
Derolf, A. Rangert
Stockelberg, D.
Tidefelt, U.
Wahlin, A.
Wennstrom, L.
Hoglund, M.
Juliusson, Gunnar

January 2011

Our knowledge about acute promyelocytic leukemia (APL) patients is mainly based on data from clinica...

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

Gurnari, Carmelo
Voso, Maria Teresa
Girardi, Katia
Mastronuzzi, Angela
Strocchio, Luisa

January 2021

Acute promyelocytic leukemia (APL) represents a paradigm of precision medicine. Indeed, in the last ...

Treatment of elderly patients (â‰¥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols

Mandelli F., Latagliata R., Avvisati G., Fazi P., Rodeghiero F., Leoni F., Gobbi M., Nobile F., Gallo E., Fanin R., Amadori S., Vignetti M., Fioritoni G., Ferrera F., Peta A., Giustolisi R., Broccia G., Petti M.C., Lo-Coco F.

January 2003

In all, 134 elderly patients (median age 66 years, range 60-75 years) with newly diagnosed acute pro...

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols

Rosati, Serena
Gurnari, Carmelo
Breccia, Massimo
Carmosino, Ida
Scalzulli, Emilia
Montefusco, Enrico
Perrone, Salvatore
Annibali, Ombretta
Martini, Vincenza
Trapè, Giulio
Colafigli, Gioia
Trawinska, Malgorzata
Minotti, Clara
Cimino, Giuseppe
Tafuri, Agostino
Avvisati, Giuseppe
Martelli, Maurizio
Voso, Maria Teresa
Latagliata, Roberto

January 2021

Acute promyelocytic leukemia (APL) is uncommon among subjects aged ≥ 70 years and the better therape...

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age

Finsinger, P
Breccia, M
Minotti, C
Carmosino, I
Girmenia, C
Chisini, M
Volpicelli, P
Vozella, F
Romano, A
Montagna, C
Colafigli, G
Cimino, G
Avvisati, G
Petti, Mc
Foa, R
Latagliata, R.
LO COCO, FRANCESCO

January 2015

All-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a very curable disease al...

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

Kayser, Sabine
Rahmé, Ramy
Martínez-Cuadrón, David
Ghiaur, Gabriel
Thomas, Xavier
Sobas, Marta
Guerci-Bresler, Agnes
Garrido, Ana
Pigneux, Arnaud
Gil, Cristina
Raffoux, Emmanuel
Tormo, Mar
Vey, Norbert
de la Serna, Javier
Salamero, Olga
Lengfelder, Eva
Levis, Mark
Fenaux, Pierre
Sanz, Miguel A..
Platzbecker, Uwe
Schlenk, Richard F.
Adès, Lionel
Montesinos, Pau
Universitat Autònoma de Barcelona

January 2020

Data on outcome in older (≥70 years) patients with acute promyelocytic leukemia after treatment with...

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Finsinger, P
Breccia, M
Minotti, C
Carmosino, I
Girmenia, C
Chisini, Marta
Volpicelli, Paola
Vozella, Federico
Romano, A
Montagna, C
Colafigli, Gioia
Cimino, Giuseppe
Avvisati, G
Petti, Mc
Lo Coco, F
Foa, Roberto
Latagliata, R.

January 2015

All-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a very curable disease al...

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Salamero, Olga
Martínez-Cuadrón, David
Sobas, Marta
Benavente, Celina
Vives, Susana
Serna, Javier de
Pérez-Encinas, Manuel
Escoda, Lourdes
Gil, Cristina
Brunet, Salut
Ramos, Fernando
Esteve, Jordi
Amigo, M. Luz
Krsnik, Isabel
Manso, Félix
Arias, Jesús
González-Campos, José A.
Serrano, Josefina
Oleksiuk, Jalanta
Barrios, Manuel
García-Boyero, Raimundo
Novo, Andrés
Sanz, Miguel Ángel
Montesinos, Pau

June 2020

PETHEMA And PALG Groups.Acute promyelocytic leukemia is infrequent among patients aged ≥75 years old...

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

Martinez-Cuadron, D.
Montesinos, P.
Vellenga, E.
Bernal, T.
Salamero, O.
Holowiecka, A.
Brunet, S.
Gil, C.
Benavente, C.
Ribera, J. M.
Perez-Encinas, M.
De la Serna, J.
Esteve, J.
Rubio, V.
Gonzalez-Campos, J.
Escoda, L.
Amutio, M. E.
Arnan, M.
Arias, J.
Negri, S.
Lowenberg, B.
Sanz, M. A.

January 2018

Treatment outcome in older patients with acute promyelocytic leukemia (APL) is lower compared with y...

REVIEWARTICLE Management of elderly patients with acute promyelocytic leukemia: progress and problems

Eva Lengfelder
Wolf-karsten Hofmann
Florian Nolte

January 2013

Abstract Despite substantial progress in the management and outcome of acute promyelocytic leukemia ...

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Kayser, Sabine
Rahmé, Ramy
Martínez-Cuadrón, David
Ghiaur, Gabriel
Thomas, Xavier
Sobas, Marta
Salamero García, Olga

September 2020

Leucèmia mieloide aguda; Genètica clínicaLeucemia mieloide aguda; Genética clínicaAcute myeloid leuk...

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults

Locatelli, Franco (ORCID:0000-0002-7976-3654)

January 2014

The outcome of adults and children with Acute Promyelocytic Leukemia (APL) has dramatically changed ...

Real-World Treatment Patterns and Outcomes among Elderly Acute Myeloid Leukemia Patients in the United States

Hoang, Sacha Satram-
Reyes, Carolina
Hurst, Deborah
Hoang, Khang Q.
Medeiros, Bruno C.

July 2016

Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. Using the l...

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY

Francesco Lococo
Roberto Latagliata
Massimo Breccia

June 2013

Unlike other forms of AML, APL is less frequently diagnosed in the elderly and has a relatively favo...

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study

Kayser, S.
Schlenk, R.F.
Lebon, D.
Carre, M.
Götze, K.S.
Stölzel, F.
Berceanu, A.
Schäfer-Eckart, K.
Peterlin, P.
Hicheri, Y.
Rahme, R.
Raffoux, E.
Chermat, F.
Krause, S.W.
Aulitzky, W.E.
Rigaudeau, S.
Noppeney, R.
Berthon, C.
Görner, M.
Jost, E.
Carassou, P.
Keller, U.
Orvain, C.
Braun, T.
Saillard, C.
Arar, A.
Kunzmann, V.
Wemeau, M.
De Wit, M.
Niemann, D.
Bonmati, C.
Schwänen, C.
Abraham, J.
Aljijakli, A.
Haiat, S.
Krämer, A.
Reichle, A.
Gnadler, M.
Willekens, C.
Spiekermann, K.
Hiddemann, W.
Müller-Tidow, C.
Thiede, C.
Röllig, C.
Serve, H.
Bornhäuser, M.
Baldus, C.D.
Lengfelder, E.
Fenaux, P.
Platzbecker, U.
Adès, L.

December 2021

The aim of this study was to characterize a large series of 154 patients with acute promyelocytic le...

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

Lehmann, S.
Ravn, A.
Carlsson, L.
Antunovic, P.
Deneberg, S.
Mollgard, L.
Derolf, A. Rangert
Stockelberg, D.
Tidefelt, U.
Wahlin, A.
Wennstrom, L.
Hoglund, M.
Juliusson, Gunnar

January 2011

Our knowledge about acute promyelocytic leukemia (APL) patients is mainly based on data from clinica...

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

Gurnari, Carmelo
Voso, Maria Teresa
Girardi, Katia
Mastronuzzi, Angela
Strocchio, Luisa

January 2021

Acute promyelocytic leukemia (APL) represents a paradigm of precision medicine. Indeed, in the last ...

Treatment of elderly patients (â‰¥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols

Mandelli F., Latagliata R., Avvisati G., Fazi P., Rodeghiero F., Leoni F., Gobbi M., Nobile F., Gallo E., Fanin R., Amadori S., Vignetti M., Fioritoni G., Ferrera F., Peta A., Giustolisi R., Broccia G., Petti M.C., Lo-Coco F.

January 2003

In all, 134 elderly patients (median age 66 years, range 60-75 years) with newly diagnosed acute pro...

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols

Rosati, Serena
Gurnari, Carmelo
Breccia, Massimo
Carmosino, Ida
Scalzulli, Emilia
Montefusco, Enrico
Perrone, Salvatore
Annibali, Ombretta
Martini, Vincenza
Trapè, Giulio
Colafigli, Gioia
Trawinska, Malgorzata
Minotti, Clara
Cimino, Giuseppe
Tafuri, Agostino
Avvisati, Giuseppe
Martelli, Maurizio
Voso, Maria Teresa
Latagliata, Roberto

January 2021

Acute promyelocytic leukemia (APL) is uncommon among subjects aged ≥ 70 years and the better therape...

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age

Finsinger, P
Breccia, M
Minotti, C
Carmosino, I
Girmenia, C
Chisini, M
Volpicelli, P
Vozella, F
Romano, A
Montagna, C
Colafigli, G
Cimino, G
Avvisati, G
Petti, Mc
Foa, R
Latagliata, R.
LO COCO, FRANCESCO

January 2015

All-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a very curable disease al...

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

Kayser, Sabine
Rahmé, Ramy
Martínez-Cuadrón, David
Ghiaur, Gabriel
Thomas, Xavier
Sobas, Marta
Guerci-Bresler, Agnes
Garrido, Ana
Pigneux, Arnaud
Gil, Cristina
Raffoux, Emmanuel
Tormo, Mar
Vey, Norbert
de la Serna, Javier
Salamero, Olga
Lengfelder, Eva
Levis, Mark
Fenaux, Pierre
Sanz, Miguel A..
Platzbecker, Uwe
Schlenk, Richard F.
Adès, Lionel
Montesinos, Pau
Universitat Autònoma de Barcelona

January 2020

Data on outcome in older (≥70 years) patients with acute promyelocytic leukemia after treatment with...

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Finsinger, P
Breccia, M
Minotti, C
Carmosino, I
Girmenia, C
Chisini, Marta
Volpicelli, Paola
Vozella, Federico
Romano, A
Montagna, C
Colafigli, Gioia
Cimino, Giuseppe
Avvisati, G
Petti, Mc
Lo Coco, F
Foa, Roberto
Latagliata, R.

January 2015

All-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a very curable disease al...

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Salamero, Olga
Martínez-Cuadrón, David
Sobas, Marta
Benavente, Celina
Vives, Susana
Serna, Javier de
Pérez-Encinas, Manuel
Escoda, Lourdes
Gil, Cristina
Brunet, Salut
Ramos, Fernando
Esteve, Jordi
Amigo, M. Luz
Krsnik, Isabel
Manso, Félix
Arias, Jesús
González-Campos, José A.
Serrano, Josefina
Oleksiuk, Jalanta
Barrios, Manuel
García-Boyero, Raimundo
Novo, Andrés
Sanz, Miguel Ángel
Montesinos, Pau

June 2020

PETHEMA And PALG Groups.Acute promyelocytic leukemia is infrequent among patients aged ≥75 years old...

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

Martinez-Cuadron, D.
Montesinos, P.
Vellenga, E.
Bernal, T.
Salamero, O.
Holowiecka, A.
Brunet, S.
Gil, C.
Benavente, C.
Ribera, J. M.
Perez-Encinas, M.
De la Serna, J.
Esteve, J.
Rubio, V.
Gonzalez-Campos, J.
Escoda, L.
Amutio, M. E.
Arnan, M.
Arias, J.
Negri, S.
Lowenberg, B.
Sanz, M. A.

January 2018

Treatment outcome in older patients with acute promyelocytic leukemia (APL) is lower compared with y...

REVIEWARTICLE Management of elderly patients with acute promyelocytic leukemia: progress and problems

Eva Lengfelder
Wolf-karsten Hofmann
Florian Nolte

January 2013

Abstract Despite substantial progress in the management and outcome of acute promyelocytic leukemia ...

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Kayser, Sabine
Rahmé, Ramy
Martínez-Cuadrón, David
Ghiaur, Gabriel
Thomas, Xavier
Sobas, Marta
Salamero García, Olga

September 2020

Leucèmia mieloide aguda; Genètica clínicaLeucemia mieloide aguda; Genética clínicaAcute myeloid leuk...

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults

Locatelli, Franco (ORCID:0000-0002-7976-3654)

January 2014

The outcome of adults and children with Acute Promyelocytic Leukemia (APL) has dramatically changed ...

Real-World Treatment Patterns and Outcomes among Elderly Acute Myeloid Leukemia Patients in the United States

Hoang, Sacha Satram-
Reyes, Carolina
Hurst, Deborah
Hoang, Khang Q.
Medeiros, Bruno C.

July 2016

Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. Using the l...

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY

Francesco Lococo
Roberto Latagliata
Massimo Breccia

June 2013

Unlike other forms of AML, APL is less frequently diagnosed in the elderly and has a relatively favo...

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study

Kayser, S.
Schlenk, R.F.
Lebon, D.
Carre, M.
Götze, K.S.
Stölzel, F.
Berceanu, A.
Schäfer-Eckart, K.
Peterlin, P.
Hicheri, Y.
Rahme, R.
Raffoux, E.
Chermat, F.
Krause, S.W.
Aulitzky, W.E.
Rigaudeau, S.
Noppeney, R.
Berthon, C.
Görner, M.
Jost, E.
Carassou, P.
Keller, U.
Orvain, C.
Braun, T.
Saillard, C.
Arar, A.
Kunzmann, V.
Wemeau, M.
De Wit, M.
Niemann, D.
Bonmati, C.
Schwänen, C.
Abraham, J.
Aljijakli, A.
Haiat, S.
Krämer, A.
Reichle, A.
Gnadler, M.
Willekens, C.
Spiekermann, K.
Hiddemann, W.
Müller-Tidow, C.
Thiede, C.
Röllig, C.
Serve, H.
Bornhäuser, M.
Baldus, C.D.
Lengfelder, E.
Fenaux, P.
Platzbecker, U.
Adès, L.

December 2021

The aim of this study was to characterize a large series of 154 patients with acute promyelocytic le...

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

Lehmann, S.
Ravn, A.
Carlsson, L.
Antunovic, P.
Deneberg, S.
Mollgard, L.
Derolf, A. Rangert
Stockelberg, D.
Tidefelt, U.
Wahlin, A.
Wennstrom, L.
Hoglund, M.
Juliusson, Gunnar

January 2011

Our knowledge about acute promyelocytic leukemia (APL) patients is mainly based on data from clinica...

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

Gurnari, Carmelo
Voso, Maria Teresa
Girardi, Katia
Mastronuzzi, Angela
Strocchio, Luisa

January 2021

Acute promyelocytic leukemia (APL) represents a paradigm of precision medicine. Indeed, in the last ...

Treatment of elderly patients (â‰¥60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols

Mandelli F., Latagliata R., Avvisati G., Fazi P., Rodeghiero F., Leoni F., Gobbi M., Nobile F., Gallo E., Fanin R., Amadori S., Vignetti M., Fioritoni G., Ferrera F., Peta A., Giustolisi R., Broccia G., Petti M.C., Lo-Coco F.

January 2003

In all, 134 elderly patients (median age 66 years, range 60-75 years) with newly diagnosed acute pro...

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols

Abstract

Extracted data

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols

Abstract

Extracted data

Related items

Related items